Gladius Capital Management’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-4,574
Closed -$194K – 78
2024
Q3
$194K Buy
4,574
+3,258
+248% +$171K 0.02% 115
2024
Q2
$67.4K Sell
1,316
-756
-36% -$42.8K 0.01% 168
2024
Q1
$130K Sell
2,072
-56
-3% -$3.81K 0.04% 141
2023
Q4
$159K Buy
2,128
+1,542
+263% +$110K 0.02% 133
2023
Q3
$49.9K Buy
586
+65
+12% +$6.16K ﹤0.01% 212
2023
Q2
$56.9K Sell
521
-16
-3% -$1.52K ﹤0.01% 189
2023
Q1
$44.5K Buy
537
+21
+4% +$1.98K ﹤0.01% 219
2022
Q4
$53.1K Sell
516
-115
-18% -$13.2K ﹤0.01% 194
2022
Q3
$67K Buy
+631
New +$69.2K ﹤0.01% 195

Other funds holding AMN

Gladius Capital Management's AMN Position: Q4 2024 in Review

Gladius Capital Management sold out of AMN Healthcare (AMN) in Q4 2024, closing a stake of 4,574 shares — an estimated $194K sold.

Gladius Capital Management first reported a position in AMN in Q3 2022 and held it in 9 quarters. The position peaked at $194K in Q3 2024. 278 funds tracked by Wall St. Rank hold AMN as of Q4 2024.

  • Gladius Capital Management reported no remaining AMN Healthcare position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 4,574 AMN Healthcare shares in Q4 2024, an estimated $194K.
  • Gladius Capital Management first reported a position in AMN Healthcare in Q3 2022 and held it in 9 quarters.
  • Gladius Capital Management's AMN Healthcare position peaked at $194K in Q3 2024.
  • 278 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.